KWALITY PHARMACEUTICALS L Share Price
KWALITY PHARMACEUTICALS L Share Price Today
As of 5 Jul 2026, KWALITY PHARMACEUTICALS L share price is ₹2,672.50. The stock opened at ₹2,779.00, compared to its previous close of ₹2,745.50. During today's trading session, KWALITY PHARMACEUTICALS L share price moved in the range of ₹2,646.40 to ₹2,787.00, with an average price of ₹2,716.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,561.00 and a high of ₹2,890.30. On the performance front, KWALITY PHARMACEUTICALS L share price has increased by 65.20% over the last six months and is up 65.20% on a year-on-year basis.
KWALITY PHARMACEUTICALS L Returns Calculator
KWALITY PHARMACEUTICALS L Shareholder Returns
KWALITY PHARMACEUTICALS L Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
KWALITY PHARMACEUTICALS L Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹370.20 | ₹307.17 | ₹251.03 | ₹456.19 |
| Other Income | ₹1.92 | ₹1.83 | ₹2.94 | ₹3.51 |
| Total Revenue | ₹372.12 | ₹309.00 | ₹253.97 | ₹459.70 |
| Total Expenses | ₹317.98 | ₹270.80 | ₹211.87 | ₹298.13 |
| Profit Before Tax | ₹54.14 | ₹31.10 | ₹25.57 | ₹161.57 |
| Tax | ₹14.34 | ₹7.48 | ₹6.29 | ₹41.63 |
| Profit After Tax | ₹39.80 | ₹23.62 | ₹19.28 | ₹119.94 |
| EPS - Basic | ₹38.36 | ₹22.76 | ₹18.16 | ₹115.12 |
| EPS - Diluted | ₹38.36 | ₹22.76 | ₹18.16 | ₹115.12 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹54.14 | ₹31.10 | ₹25.57 | ₹161.57 |
| Income before WC changes | ₹82.14 | ₹67.72 | ₹46.52 | ₹175.13 |
| Change in Assets | -₹31.33 | -₹41.49 | ₹14.55 | -₹118.64 |
| Change in Liabilities | ₹17.69 | ₹18.06 | -₹13.54 | ₹45.47 |
| Change in WC | -₹13.64 | -₹23.44 | ₹1.01 | -₹73.18 |
| Cash flow from Operations | ₹52.72 | ₹42.98 | ₹41.38 | ₹60.60 |
| Cash flow from Investing | -₹28.52 | -₹26.40 | -₹48.44 | -₹62.93 |
| Cash flow from Financing | -₹14.44 | -₹17.40 | ₹0.99 | ₹5.66 |
| Total Cash Flow | ₹9.76 | -₹0.81 | -₹6.07 | ₹3.33 |
| Cash (Start of the year) | ₹2.26 | ₹3.07 | ₹9.13 | ₹5.81 |
| Cash (End of the year) | ₹12.02 | ₹2.26 | ₹3.07 | ₹9.13 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹163.49 | ₹151.52 | ₹146.43 | ₹112.77 |
| Current Assets | ₹283.78 | ₹242.69 | ₹207.20 | ₹227.82 |
| Total Assets | ₹447.27 | ₹394.21 | ₹353.63 | ₹340.59 |
| Current Liabilities | ₹169.51 | ₹151.85 | ₹125.95 | ₹139.49 |
| Net Current Asset | ₹114.27 | ₹90.84 | ₹81.25 | ₹88.33 |
| Non-Current Liabilities | ₹15.37 | ₹19.78 | ₹28.62 | ₹21.32 |
| Equity Capital | ₹262.40 | ₹222.58 | ₹199.07 | ₹179.79 |
| Total Equity & Liabilities | ₹447.27 | ₹394.21 | ₹353.63 | ₹340.59 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹370.20 | ₹307.17 | ₹250.99 | ₹456.13 |
| Other Income | ₹1.92 | ₹1.83 | ₹2.94 | ₹3.51 |
| Total Revenue | ₹372.12 | ₹309.00 | ₹253.94 | ₹459.64 |
| Total Expenses | ₹317.89 | ₹270.44 | ₹211.65 | ₹297.97 |
| Profit Before Tax | ₹54.23 | ₹31.47 | ₹25.76 | ₹161.67 |
| Tax | ₹14.34 | ₹7.48 | ₹6.29 | ₹41.63 |
| Profit After Tax | ₹39.89 | ₹23.98 | ₹19.47 | ₹120.05 |
| EPS - Basic | ₹38.44 | ₹23.11 | ₹18.45 | ₹115.36 |
| EPS - Diluted | ₹38.44 | ₹23.11 | ₹18.45 | ₹115.36 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹54.23 | ₹31.47 | ₹25.76 | ₹161.67 |
| Income before WC changes | ₹82.20 | ₹68.08 | ₹46.67 | ₹175.19 |
| Change in Assets | -₹31.33 | -₹41.49 | ₹14.54 | -₹119.51 |
| Change in Liabilities | ₹17.69 | ₹18.07 | -₹12.86 | ₹44.92 |
| Change in WC | -₹13.64 | -₹23.43 | ₹1.67 | -₹74.59 |
| Cash flow from Operations | ₹52.77 | ₹43.35 | ₹42.19 | ₹59.24 |
| Cash flow from Investing | -₹28.13 | -₹26.40 | -₹48.44 | -₹62.98 |
| Cash flow from Financing | -₹14.44 | -₹17.40 | ₹0.99 | ₹5.66 |
| Total Cash Flow | ₹10.20 | -₹0.45 | -₹5.26 | ₹1.93 |
| Cash (Start of the year) | ₹1.35 | ₹1.80 | ₹7.06 | ₹5.13 |
| Cash (End of the year) | ₹11.55 | ₹1.35 | ₹1.80 | ₹7.06 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹165.82 | ₹154.19 | ₹149.06 | ₹115.36 |
| Current Assets | ₹284.90 | ₹243.38 | ₹207.52 | ₹227.32 |
| Total Assets | ₹450.72 | ₹397.57 | ₹356.58 | ₹342.68 |
| Current Liabilities | ₹169.51 | ₹151.85 | ₹125.94 | ₹138.80 |
| Net Current Asset | ₹115.40 | ₹91.53 | ₹81.58 | ₹88.51 |
| Non-Current Liabilities | ₹15.37 | ₹19.78 | ₹28.62 | ₹21.32 |
| Equity Capital | ₹265.84 | ₹225.95 | ₹202.03 | ₹182.56 |
| Total Equity & Liabilities | ₹450.72 | ₹397.57 | ₹356.58 | ₹342.68 |
About KWALITY PHARMACEUTICALS L
Kwality Pharmaceuticals Limited is an India-based company, which engages in the manufacturing & trading in pharmaceuticals & allied products. It engages in the business of manufacturers, buyers and sellers of and dealers in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. It also engages in research and development activities. It manufactures exports pharmaceutical formulations in liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations, oral rehydration solutions (ORS), and others in various categories like beta lactam and non-beta lactam, hormones, cytotoxic (oncology) and effervescent. The Company has approximately 48 different sections available at their production centers. Its subsidiary is Kwality Pharmaceuticals Africa Limitada.
KWALITY PHARMACEUTICALS L Financial Highlights
- Revenue: KWALITY PHARMACEUTICALS L reported revenue of ₹505.94 crore in FY26 vs ₹372.12 crore in FY25. It showed an increase of 35.96% on a yearly basis.
- Operating Profit: KWALITY PHARMACEUTICALS L reported an operating profit of ₹89.49 crore in FY26 vs ₹54.14 crore in FY25. It showed an increase of 65.29% on a year-on-year basis.
- Net Profit: KWALITY PHARMACEUTICALS L reported a net profit of ₹67.35 crore in FY26 vs ₹39.80 crore in FY25. It showed an increase of 69.22% on a yearly basis.
KWALITY PHARMACEUTICALS L Quarterly Result Highlights
- KWALITY PHARMACEUTICALS L reported revenue of ₹158.17 crore in Mar 2026, compared with ₹123.97 crore in Dec 2025, representing an increase of 27.59% on a quarter-on-quarter (QoQ) basis.
- KWALITY PHARMACEUTICALS L reported an operating profit of ₹31.67 crore in Mar 2026, compared with ₹22.35 crore in Dec 2025, representing an increase of 41.70% on a quarter-on-quarter (QoQ) basis.
- KWALITY PHARMACEUTICALS L reported a profit of ₹25.31 crore in Mar 2026, compared with ₹16.00 crore in Dec 2025, reflecting an increase of 58.19% on a QoQ basis.
- The earnings per share (EPS) of KWALITY PHARMACEUTICALS L stood at ₹38.36 during Mar 2026.
Similar Stocks
FAQs on KWALITY PHARMACEUTICALS L Share Price
What is KWALITY PHARMACEUTICALS L share price today?
KWALITY PHARMACEUTICALS L share price is ₹2,672.50 as on 03 Jul, 2026, 15:29 IST.
How has the KWALITY PHARMACEUTICALS L share price performed in the past?
In the last 1 year, KWALITY PHARMACEUTICALS L delivered a return of 65.20%. The KWALITY PHARMACEUTICALS L share price hit a high of ₹2,890.30 and low of ₹1,561.00.
How much is the Mutual Fund shareholding in KWALITY PHARMACEUTICALS L shares?
The Mutual Fund Shareholding in KWALITY PHARMACEUTICALS L was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of KWALITY PHARMACEUTICALS L shares ?
The 52-week high and low of KWALITY PHARMACEUTICALS L share is ₹2,890.30 and ₹1,561.00 as of 03 Jul, 2026.
What is the market cap of KWALITY PHARMACEUTICALS L?
The market capitalisation of KWALITY PHARMACEUTICALS L is ₹2,826.63 Crores as on 03 Jul, 2026.
What are the stock symbols of KWALITY PHARMACEUTICALS L?
The stock symbol of KWALITY PHARMACEUTICALS L is KPL on the NSE, 539997 on the BSE, and the ISIN is INE552U01010.
What was yesterday's closing price of KWALITY PHARMACEUTICALS L shares ?
KWALITY PHARMACEUTICALS L shares closed yesterday at ₹2,745.50 on NSE & ₹2,724.15 on BSE
How to buy KWALITY PHARMACEUTICALS L shares?
To buy KWALITY PHARMACEUTICALS L shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy KWALITY PHARMACEUTICALS L shares on Holidays?
No, shares of KWALITY PHARMACEUTICALS L or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell KWALITY PHARMACEUTICALS L shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of KWALITY PHARMACEUTICALS L?
The PE and PB ratio of KWALITY PHARMACEUTICALS L is 41.97 and 8.54 respectively, as on 03 Jul, 2026, 15:29 IST.